Bistability and long-term cure in a within-host model of hepatitis C

Journal of Biological Systems

Volumn 19, Issue 4, 2011, Pages 533-550

  Debroy, Swati ^a   Bolker, Benjamin M ^b   Martcheva, Maia ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Backward Bifurcation; Bistability; HCV; Hepatitis C; Sustained Virological Response; SVR

Indexed keywords

HEPATITIS C VIRUS;

EID: 84555188619     PISSN: 02183390     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0218339011004135     Document Type: Article

References (31)

1. Narkowicz M, Cabrera R, Gonzlez-Peralta RP, The "C" of viral hepatitis in children, Semin Liver Dis 27:295-311, 2007.
2. Wong JB, McQuillan GM, McHutchison JG, Poynard T, Estimating future hepatitis C morbidity, mortality, and costs in the United States, Am J Public Health 90(10):1562-1569, 2000.
3. Ghany MG, Strader DB, Thomas DL, Seeff LB, Diagnosis, management, and treatment of hepatitis C: An update, Hepatology 49(4):1335-1374, 2009.
4. Seeff LB, Natural history of chronic hepatitis C, Hepatology 36:S35-S46, 2002. (Pubitemid 35253462)
5. Neumann UA, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS, Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy, Science 282(2):103-107, 1998. (Pubitemid 28471138)
6. Lee SS, Ferenci P, Optimizing outcomes in patients with hepatitis C virus genotype 1 or 4, Antivira Therapy 13:9-16, 2008. (Pubitemid 351542493)
7. Yu JW, Wang GQ, Sun LJ, Li XG, Li SC, Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon alpha-2a and ribavirin, J Gastroenterol Hepatol 22:832-836, 2007.
8. Jensen DM, Morgan TR, Marcellin P, Pockros PJ, Reddy KR, Hadziyannis SJ, Ferenci P, Ackrill AM, Willems B, Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy, Hepatology 43:954-960, 2006. (Pubitemid 43724620)
9. Davis GL, Wong JB, McHutchison JG, Manns MP, Harvey J, Albrecht J, Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C, Hepatology 38(3):645-652, Sept 2003. (Pubitemid 37052151)
10. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales Jr FL, Hussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J, Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection, New Engl J Med 347:975-982, 2002.
11. Dahari H, Loa A, Ribeiroa RM, Perelson AS, Modeling hepatitis C virus dynamics: Liver regeneration and critical drug efficacy, J Theor Biol 247:371-381, 2007. (Pubitemid 46863436)
12. Dixit NM, Layden-Almer JE, Layden TJ, Perelson AS, Modelling how ribavirin improves interferon response rates in hepatitis C virus infection, Nature 432:922-924, 2004. (Pubitemid 40037156)
13. Dahari H, Ribeiro RM, Perelson AS, Triphasic decline of hepatitis C virus RNA during antiviral decline, Hepatology 46:16-21, July 2007. (Pubitemid 47171916)
14. Reluga TC, Dahari H, Perelson A, Analysis of hepatitis C virus infection models with hepatocyte homeostasis, SIAM J Appl Math 69(4):999-1023, 2009.
15. Snoeck E, Chanu P, Lavielle M, Jacqmin P, Jonsson EN, Jorga K, Goggin T, Grippo J, Jumbe NL, Frey N, A comprehensive hepatitis C viral kinetic model explaining cure, Nature 87(6):706-713, 2010.
16. + T cells, Bull Math Biol 67:101-114, 2005. (Pubitemid 40181070)
17. Dahari H, Layden-Almer JE, Kallwitz E, Ribieiro RM, Cotler SJ, Thomas TJ, Perelson AS, A mathematical model of hepatitis C virus dynamics in patients with high baseline viral loads or advanced liver disease, Gastroenterology 136:1402-1409, 2009.
18. Dahari H, Shudo E, Cotler SJ, Layden TJ, Perelson AS, Modelling hepatitis C virus kinetics: the relationship between the infected cell loss rate and the final slope of viral decay, Antiviral Therapy 14:459-464, 2009.
19. Dahari H, Shudo E, Ribieiro RM, Perelson AS, Modeling complex decay profiles of hepatitis B virus during antiviral therapy, Hepatology 49:32-38, 2009.
20. Brauer F, Castillo-Chavez C, Mathematical Models in Population Biology and Epidemiology, Springer-Verlag, New York.
21. Kribs-Zaleta CM, Martcheva M, Vaccination strategies and backward bifurcation in an age-since-infection structured model, Math Biosci 177-178:317-332, 2002. (Pubitemid 34457396)
22. Block TM, Mehta AS, Fimmel CJ, Jordan R, Molecular viral oncology of hepatocellular carcinoma, Oncogene 22:5093-5107, 2003. (Pubitemid 37059591)
23. Jensen DM, Marcellin P, Freilich B, Andreone P, Bisceglie AD, Brando-Mello CE, Reddy KR, Craxi A, Martin AO, Teuber G, Messinger D, Thommes JA, Tietz A, Re-treatment of patients with chronic hepatitis C who do not respond to peginterferon- ? 2b: A randomized trial, Ann Intern Med 150:528-540, 2009.
24. Lam NP, Neumann AU, Gretch DR, Wiley TE, Perelson AS, Layden TJ, Dosedependent acute clearance of hepatitis C genotype 1 virus with interferon alpha, Hepatology 26:226-231, 1997. (Pubitemid 27280329)
25. Dushoff J, Huang W, Castillo-Chavez C, Backwards bifurcations and catastrophe in simple models of fatal diseases, J Math Biol 36:227-248, 1998. (Pubitemid 128735143)
26. Feng Z, Castillo-Chavez C, Capurro A, A model for tuberculosis with exogeneous reinfection, Theor Pop Biol 57:235-247, 2000.
27. Qesmi R, Wub J, Wua J, Heffernan JM, Influence of backward bifurcation in a model of hepatitis B and C viruses, Math Biosci 224:118-125, 2010.
28. Chakrabarty SP, Joshi HR, Optimally controlled treatment strategy using interferon and ribavirin for hepatitis C, J Biol Syst 17(1):97-110, 2009.
29. DebRoy S, Kribs-Zaleta C, Mubayi A, Cardona-Melendez G, Medina-Rios L, Kang M, Diaz E, Evaluating treatment of hepatitis C for hemolytic anemia management, Math Biosci 225:141-155, 2010.
30. Hellriegel B, Immunoepidemiology bridging the gap between immunology and epidemiology, Trends Parasitol 17:102-106, 2001. (Pubitemid 32416558)
31. Sloot PMA, Boukhanovsky AV, Keulen W, Tirado-Ramos A, Boucher CA, A gridbased HIV expert system, J Clin Monit Comput 19(4-5):263-278, 2005.